Literature DB >> 21303600

Comparison of speech and aesthetic outcomes in patients with maxillary reconstruction versus maxillary obturators after maxillectomy.

Jana M Rieger1, Judith A Lam Tang, Johan Wolfaardt, Jeffrey Harris, Hadi Seikaly.   

Abstract

BACKGROUND: Two options exist for restoring structure and function after maxillectomy. Prosthodontic rehabilitation requires that an obturator be constructed to address the oronasal communication that exists after resection of the maxilla. Surgical reconstruction of the defect is another option, often accomplished with the use of bone-containing flaps.
OBJECTIVE: To determine whether prosthetic rehabilitation or surgical reconstruction of the maxilla provides better speech and facial aesthetic outcomes after maxillectomy. DESIGN, PARTICIPANTS, AND MEASURES: Fifty-nine patients in three groups were included: 23 patients with maxillary obturators, 16 patients with maxillary reconstruction, and 20 patients without any maxillary defects but who were diagnosed with nasopharyngeal cancer and who served as a control group. Using digitized photographs, facial attractiveness was rated on a 10-point scale by eight judges who were blinded to treatment group. Speech outcomes included nasalance, velopharyngeal orifice opening, and speech intelligibility. RESULTS AND
CONCLUSIONS: There were no significant between-group differences found for facial attractiveness ratings. However, patients in either group who had involvement of the orbital rim or the orbital rim and zygoma were rated as significantly less attractive than those without such involvement. With respect to speech outcomes, the control group (ie, nasopharynx) had smaller velopharyngeal orifice areas than the obturator group; however, this was not clinically significant as scores in both groups were within normal limits. In conclusion, this study found no differences between surgical reconstruction or prosthodontic intervention of maxillary defects when facial attractiveness was assessed by naive raters and speech outcomes were assessed using objective measurements.

Entities:  

Mesh:

Year:  2011        PMID: 21303600

Source DB:  PubMed          Journal:  J Otolaryngol Head Neck Surg        ISSN: 1916-0208


  5 in total

1.  A survey of variables used by speech-language pathologists to assess function and predict functional recovery in oral cancer patients.

Authors:  Hasan Husaini; Gintas P Krisciunas; Susan Langmore; Jacqueline K Mojica; Mark L Urken; Adam S Jacobson; Cathy L Lazarus
Journal:  Dysphagia       Date:  2014-03-08       Impact factor: 3.438

2.  Development of a Patient-Centered Functional Outcomes Questionnaire in Head and Neck Cancer.

Authors:  Adrian Mendez; Hadi Seikaly; Dean Eurich; Agnieszka Dzioba; Daniel Aalto; Martin Osswald; Jeffrey R Harris; Daniel A O'Connell; Cathy Lazarus; Mark Urken; Ilya Likhterov; Raymond L Chai; Erika Rauscher; Daniel Buchbinder; Devin Okay; Risto-Pekka Happonen; Ilpo Kinnunen; Heikki Irjala; Tero Soukka; Juhani Laine
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

3.  Prosthetic versus surgical rehabilitation in patients with maxillary defect regarding the quality of life: systematic review.

Authors:  M Y Sharaf; S I Ibrahim; A E Eskander; A F Shaker
Journal:  Oral Maxillofac Surg       Date:  2018-01-31

4.  Obturator Prosthesis Rehabilitation after Maxillectomy: Functional and Aesthetical Analysis in 25 Patients.

Authors:  Massimo Corsalini; Giuseppe Barile; Santo Catapano; Annamaria Ciocia; Assunta Casorelli; Rosaria Siciliani; Daniela Di Venere; Saverio Capodiferro
Journal:  Int J Environ Res Public Health       Date:  2021-11-28       Impact factor: 3.390

5.  Evaluation and comparison of oral function after resection of cancer of the upper gingiva in patients who underwent reconstruction surgery versus those treated with a prosthesis.

Authors:  Yu Ohashi; Kiyoto Shiga; Katsunori Katagiri; Daisuke Saito; Shin-Ichi Oikawa; Kodai Tsuchida; Aya Ikeda; Jun Miyaguchi; Takahiro Kusaka; Hiroyuki Yamada
Journal:  BMC Oral Health       Date:  2021-07-15       Impact factor: 2.757

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.